Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2016.11.001
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Tumor Genomic Profiling Guides Metastatic Gastric Cancer Patients to Targeted Treatment: The VIKTORY Umbrella Trial

Cancer Discovery
Oncology
2019English

Successful Treatment of Carcinomatous Meningitis With Erlotinib and Whole Brain Radiotherapy

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
2012English

EGFR Inhibitors in Treatment of Lung Adenocarcinoma

Research in Oncology
2014English

P2.13-11 EGFR Amplification and Sensitizing Mutations Correlates With Survival From Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAP¶)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits From Trastuzumab

Case Reports in Oncological Medicine
Oncology
2020English

MS18.03 Treatment of SCLC Transformed From EGFR Mutant Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Precision Medicine Approaches to Lung Adenocarcinoma With Concomitant MET and HER2 Amplification

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases
PulmonaryInfectious DiseasesRespiratory Medicine
2011English

Successful Treatment of a 67-Year-Old Woman With Urethral Adenocarcinoma With the Use of External Beam Radiotherapy and Image Guided Adaptive Interstitial Brachytherapy

Journal of Contemporary Brachytherapy
Nuclear MedicineRadiologyImagingOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy